MedinCell Statistics
Total Valuation
MedinCell has a market cap or net worth of EUR 542.19 million. The enterprise value is 587.44 million.
Market Cap | 542.19M |
Enterprise Value | 587.44M |
Important Dates
The next estimated earnings date is Thursday, September 19, 2024.
Earnings Date | Sep 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MedinCell has 29.09 million shares outstanding. The number of shares has increased by 0.01% in one year.
Shares Outstanding | 29.09M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 15.85% |
Owned by Institutions (%) | 28.22% |
Float | 20.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 44.35 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -23.46 |
EV / Sales | 49.18 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -47.97 |
Financial Position
The company has a current ratio of 1.66
Current Ratio | 1.66 |
Quick Ratio | 1.59 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -5.28 |
Interest Coverage | -4.54 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -39.49% |
Return on Capital (ROIC) | -66.61% |
Revenue Per Employee | 89,142 |
Profits Per Employee | -186,851 |
Employee Count | 134 |
Asset Turnover | 0.36 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +178.21% in the last 52 weeks. The beta is 1.17, so MedinCell's price volatility has been higher than the market average.
Beta (5Y) | 1.17 |
52-Week Price Change | +178.21% |
50-Day Moving Average | 15.75 |
200-Day Moving Average | 11.44 |
Relative Strength Index (RSI) | 71.69 |
Average Volume (20 Days) | 71,724 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedinCell had revenue of EUR 11.95 million and -25.04 million in losses. Loss per share was -0.88.
Revenue | 11.95M |
Gross Profit | 11.95M |
Operating Income | -20.94M |
Pretax Income | -24.95M |
Net Income | -25.04M |
EBITDA | -20.05M |
EBIT | -20.94M |
Loss Per Share | -0.88 |
Balance Sheet
The company has 19.46 million in cash and 64.71 million in debt, giving a net cash position of -45.25 million or -1.56 per share.
Cash & Cash Equivalents | 19.46M |
Total Debt | 64.71M |
Net Cash | -45.25M |
Net Cash Per Share | -1.56 |
Equity (Book Value) | -40.82M |
Book Value Per Share | -1.40 |
Working Capital | 10.79M |
Cash Flow
In the last 12 months, operating cash flow was -11.92 million and capital expenditures -324,000, giving a free cash flow of -12.25 million.
Operating Cash Flow | -11.92M |
Capital Expenditures | -324,000 |
Free Cash Flow | -12.25M |
FCF Per Share | -0.42 |
Margins
Gross margin is 100.00%, with operating and profit margins of -175.30% and -209.61%.
Gross Margin | 100.00% |
Operating Margin | -175.30% |
Pretax Margin | -208.87% |
Profit Margin | -209.61% |
EBITDA Margin | -167.82% |
EBIT Margin | -175.30% |
FCF Margin | -102.52% |
Dividends & Yields
MedinCell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | -0.01% |
Earnings Yield | -4.73% |
FCF Yield | -2.26% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |